Has James Daubert, MD received payments from drug or device companies?

Yes. Drug and device makers reported $98,856 in general payments to James Daubert, MD across 174 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Daubert, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Daubert, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Daubert, MD

Cardiovascular Disease · Rochester, NYNPI 1104865278

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $78,498 of the $98,856 with a category attached, or 79.4%. 7 manufacturers reported payments, led by Medtronic at 42.6% of the total. Reporting peaked in 2020 at $24,806 and has fallen 68.2% since, to $7,891 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,856in general payments, 2019–2025

Across 174 payments — averaging $568.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$42K
Boston Scientific$23K
Biosense Webster, Inc.$22K
Acutus Medical, Inc.$6K
Biotronik Inc.$5K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$864
plus $16 from 1 others

$65,891in research payments, 2019–2025

Across 14 payments — averaging $4706.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$66K

What the payments were for

Consulting fees$78,49879%
Speaking & faculty fees$6,7507%
Travel & lodging$9,3359%
Food & beverage$4,2734%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	73	$42,104
Boston Scientific	49	$22,781
Biosense Webster, Inc.	27	$22,048
Acutus Medical, Inc.	3	$6,225
Biotronik Inc.	11	$4,818
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	10	$864
Novo Nordisk	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,856 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024

$140,090

Medicare patients

604

Services billed

1,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	283	$299,540
XareltoRivaroxaban	55	$69,288
MultaqDronedarone Hcl	16	$24,107
Dofetilide	25	$8,674
Amiodarone Hcl	62	$2,891
Metoprolol Succinate	169	$2,808
Flecainide Acetate	54	$1,972
Diltiazem 24hr Er (Cd)Diltiazem Hcl	30	$1,040
Atorvastatin Calcium	18	$157
Lisinopril	22	$155
Losartan Potassium	13	$141
Metoprolol Tartrate	28	$140

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Rochester

James EichelbergerRochester$332K
Roger HajjarNew York$5.2M
Szilard VorosStony Brook$3.7M
Gregg StoneNew York$2M
Augustin DelagoAlbany$1.8M
Philippe GenereuxNew York$1.3M
Adam RosenbluthNew York$1.1M
Luigi di BiaseBronx$978K
Vijay IyerAmherst$855K
Megha PrasadNew York$813K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →